- Home
- OABI vs ARQ Comparison
OABI vs ARQ Comparison
Compare OABI & ARQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- ARQ
- Stock Information
- Founded
- OABI 2012
- ARQ 1996
- Country
- OABI United States
- ARQ United States
- Employees
- OABI N/A
- ARQ N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- ARQ
- Sector
- OABI Health Care
- ARQ
- Exchange
- OABI Nasdaq
- ARQ NYSE
- Market Cap
- OABI 185.9M
- ARQ 155.3M
- IPO Year
- OABI N/A
- ARQ N/A
- Fundamental
- Price
- OABI $1.38
- ARQ $5.14
- Analyst Decision
- OABI Strong Buy
- ARQ Strong Buy
- Analyst Count
- OABI 3
- ARQ 1
- Target Price
- OABI $7.00
- ARQ $8.00
- AVG Volume (30 Days)
- OABI 953.8K
- ARQ 254.5K
- Earning Date
- OABI 05-08-2025
- ARQ 05-07-2025
- Dividend Yield
- OABI N/A
- ARQ N/A
- EPS Growth
- OABI N/A
- ARQ N/A
- EPS
- OABI N/A
- ARQ N/A
- Revenue
- OABI $26,744,000.00
- ARQ $114,466,000.00
- Revenue This Year
- OABI N/A
- ARQ $10.91
- Revenue Next Year
- OABI $40.06
- ARQ $32.95
- P/E Ratio
- OABI N/A
- ARQ N/A
- Revenue Growth
- OABI 27.07
- ARQ 14.33
- 52 Week Low
- OABI $1.22
- ARQ $3.34
- 52 Week High
- OABI $4.96
- ARQ $8.11
- Technical
- Relative Strength Index (RSI)
- OABI 39.15
- ARQ 65.21
- Support Level
- OABI $1.22
- ARQ $4.89
- Resistance Level
- OABI $1.42
- ARQ $5.27
- Average True Range (ATR)
- OABI 0.08
- ARQ 0.32
- MACD
- OABI 0.03
- ARQ 0.07
- Stochastic Oscillator
- OABI 39.02
- ARQ 83.46
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.